Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Canadian Imperial Bank of Commerce
CM
4
Bank of Montreal
BMO
5
The Toronto-Dominion Bank
TD
加拿大市場個股詳情
FH Filament Health Corp
- 0.035
- -0.005-12.50%
延時15分鐘行情已收盤 01/21 15:45 (美東)
916.28萬總市值-1.75市盈率TTM
0.040最高價0.035最低價1.10萬股成交量0.035今開0.040昨收390.00成交額0.08552周最高0.00%換手率2.62億總股本0.02552周最低-0.02每股收益TTM916.28萬流通值0.500歷史最高虧損市盈率(靜)2.62億流通股0.025歷史最低-0.03每股收益(静)12.50%振幅--股息TTM3.50市淨率1股每手--股息率TTM
關於Filament Health Corp公司
Filament Health Corp 是一家天然的迷幻藥物開發公司。它的使命是讓所有需要的人儘快獲得安全、經批准的天然迷幻藥物。該集團利用其知識產權組合、內部GMP設施和加拿大衛生部迷幻藥經銷商許可證，從事自然提取技術的商業化。
公司介紹
公司代碼FH
公司名稱Filament Health Corp
成立日期2021
所屬市場NEOE
員工數量13
年結日12-31
公司地址4475 Wayburne Drive Unit 210
城市Burnaby
國家CAN
郵編V5G 4X4
董事高管
- 姓名
- 職務
- 年薪
- Benjamin Lightburn
- Chief Executive Officer and Chairman of the Board
- --
- Steven Nguyen
- Interim Chief Financial Officer
- --
- Ryan Moss
- Chief Science Officer
- --
- Lisa Ranken
- Chief Operating Officer
- --
- Anna Cordon
- Vice President, Marketing and Communications
- --
- Andry Tjahyana
- Vice President, Business Development
- --
- Taran Grey
- Director, Intellectual Property
- --
- Jon Conlin
- Director
- --
- Beatriz Ramos
- Director, Quality
- --
- Michael Messinger
- Director
- --
- Konstantin Aday
- Director
- --
- Sara Burke
- Head of Global Partnerships
- --
- Jeff Fellows
- Head of Regulatory
- --